What is Institutional Eye Care?
Institutional Eye Care operates as the premier provider of on-site vision services for the United States correctional system, a position it has maintained for over four decades. The company manages a sophisticated network of more than 150 licensed optometrists and ophthalmologists, delivering essential medical care across 35 states. Their service portfolio is comprehensive, encompassing routine refractions, dilated retina examinations, and complex ophthalmological diagnostics. Beyond clinical care, the firm is a critical supplier of prescription eyewear engineered to meet stringent federal safety standards, ensuring that vision health remains a consistent component of institutional medical infrastructure.
How much funding has Institutional Eye Care raised?
Institutional Eye Care has raised a total of $383K across 2 funding rounds:
Debt
$150K
Debt
$233K
Debt (2020): $150K with participation from PPP
Debt (2021): $233K led by PPP
Key Investors in Institutional Eye Care
PPP
Public-Private Partnership
What's next for Institutional Eye Care?
With the recent influx of capital, Institutional Eye Care is well-positioned to optimize its service delivery model and expand its footprint within the domestic correctional landscape. The strategic deployment of these funds will likely focus on enhancing diagnostic technology and streamlining the supply chain for safety-compliant eyewear. As the company transitions through this late-stage growth phase, the focus remains on maintaining high-quality clinical outcomes while scaling operations to meet the evolving needs of state and federal facilities. This financial backing provides the necessary liquidity to sustain long-term service contracts and reinforce the company's competitive moat in a highly specialized healthcare vertical.
See full Institutional Eye Care company page
